These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6077919)

  • 1. Binding of roentgenographic contrast media to serum albumin.
    Lang JH; Lasser EC
    Invest Radiol; 1967; 2(6):396-400. PubMed ID: 6077919
    [No Abstract]   [Full Text] [Related]  

  • 2. The interaction of iopanoic and iophenoxic acids with human serum albumin.
    Fehske KJ; Müller WE
    Res Commun Chem Pathol Pharmacol; 1978 Jan; 19(1):119-27. PubMed ID: 625581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optical studies of drug-protein complexes. 3. Interaction of flufenamic acid and other N-arylanthranilates with serum albumin.
    Chignell CF
    Mol Pharmacol; 1969 Sep; 5(5):455-62. PubMed ID: 5823761
    [No Abstract]   [Full Text] [Related]  

  • 4. Activation of serum complement by contrast media.
    Lang JH; Lasser EC; Kolb WP
    Invest Radiol; 1976; 11(4):303-8. PubMed ID: 955839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Determination of noradioactive labelled thyroid hormones and iodotyrosines besides iodine containing contrast media in the serum].
    Ködding R; Krüskemper HL
    Klin Wochenschr; 1968 Feb; 46(3):143-5. PubMed ID: 5662358
    [No Abstract]   [Full Text] [Related]  

  • 6. Fluorescence of free and protein-bound auramine O.
    Chen RF
    Arch Biochem Biophys; 1977 Mar; 179(2):672-81. PubMed ID: 851363
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of phenobarbital on iodipamide and iopanoate bile excretion.
    Nelson JA; Pepper HW; Goldberg HI; Moss AA; Amberg JR
    Invest Radiol; 1973; 8(3):126-30. PubMed ID: 4710631
    [No Abstract]   [Full Text] [Related]  

  • 8. Influence of intravenous injection rate on protein binding and vascular activity of diazoxide.
    Sellers EM; Koch-Weser J
    Ann N Y Acad Sci; 1973 Nov; 226():319-32. PubMed ID: 4520400
    [No Abstract]   [Full Text] [Related]  

  • 9. [Reaction of endogenous and exogenous iodine compounds in the serum with a basic ion exchanger].
    Ködding R; Krüskemper HL
    Z Klin Chem Klin Biochem; 1970 Jul; 8(4):425-30. PubMed ID: 4194809
    [No Abstract]   [Full Text] [Related]  

  • 10. Fluorescence stopped-flow study of relaxation processes in the binding of bilirubin to serum albumins.
    Chen RF
    Arch Biochem Biophys; 1974 Jan; 160(1):106-12. PubMed ID: 4828520
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacokinetics of a hepatotropic and a renotropic x-ray contrast agent under haemodialysis.
    Siemensen HC; Augustin HJ
    Int Urol Nephrol; 1973 Apr; 5(2):195-204. PubMed ID: 4774523
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of fatty acids on the binding of 1-anilino-8-naphthalenesulfonate to bovine serum albumin.
    Santos EC; Spector AA
    Biochemistry; 1972 Jun; 11(12):2299-302. PubMed ID: 5063739
    [No Abstract]   [Full Text] [Related]  

  • 13. Determination of the thyroxine iodine content of serum contaminated by organic iodines. A method based on gel filtration.
    Jones JE; Shultz JS
    J Clin Endocrinol Metab; 1967 Jun; 27(6):877-84. PubMed ID: 4165126
    [No Abstract]   [Full Text] [Related]  

  • 14. The binding behavior of phenothiazines and structurally related compounds to albumin from several species.
    Gabay S; Huang PC
    Adv Biochem Psychopharmacol; 1974; 9(0):175-89. PubMed ID: 4151762
    [No Abstract]   [Full Text] [Related]  

  • 15. Competition for binding to multiple sites of human serum albumin for cholecystographic agents and sulfobromophthalein.
    Mudge GH; Stibitz GR; Robinson MS; Gemborys MW
    Drug Metab Dispos; 1978; 6(4):440-51. PubMed ID: 28925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interaction of cefotaxime with the serum albumin of several mammalian species.
    Fernández GM; Lumbreras JM; Sanchez JA; Ordoñez D
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1991; 100(3):413-5. PubMed ID: 1687536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Removal of fatty acids from serum albumin by charcoal treatment.
    Chen RF
    J Biol Chem; 1967 Jan; 242(2):173-81. PubMed ID: 6016603
    [No Abstract]   [Full Text] [Related]  

  • 18. The binding of intravenous and oral biliary contrast agents to human and bovine serum albumin.
    Müller WE
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Apr; 302(2):227-33. PubMed ID: 26028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study of the binding to human serum albumin of biliscopine (a new cholangiographic contrast medium) and five other contrast media.
    Mathieu J; Looze Y; Deconinck M
    Rofo; 1979 Apr; 130(4):418-20. PubMed ID: 155594
    [No Abstract]   [Full Text] [Related]  

  • 20. The binding of various mercurial compounds to serum proteins.
    Fang SC; Fallin E
    Bull Environ Contam Toxicol; 1976 Jan; 15(1):110-7. PubMed ID: 945095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.